The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
Open accessAbstract
BACKGROUND: The effectiveness of various solutions instilled into the central venous catheter lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of catheter malfunction and bacteremia in patients undergoing hemodialysis is unknown. METHODS: We randomly assigned 225 patients undergoing long-term hemodialysis in whom a central venous catheter had been newly inserted to a catheter-locking regimen of heparin (5000 U per milliliter) three times per week or recombinant tissue plasminogen activator (rt-PA) (1 mg in each lumen) substituted for heparin at the midweek session (with heparin used in the other two sessions). The primary outcome was catheter malfunction, and the secondary outcome was catheter-related bacteremia. The treatment period was 6 months; treatment assignments were concealed from the patients, investigators, and trial personnel. RESULTS: A catheter malfunction occurred in 40 of the 115 patients assigned to heparin only (34.8%) and 22 of the 110 patients assigned to rt-PA (20.0%)--an increase in the risk of catheter malfunction by a factor of almost 2 among patients treated with heparin only as compared with those treated with rt-PA once weekly (hazard ratio, 1.91; 95% confidence interval [CI], 1.13 to 3.22; P = 0.02). Catheter-related bacteremia occurred in 15 patients (13.0%) assigned to heparin only, as compared with 5 (4.5%) assigned to rt-PA (corresponding to 1.37 and 0.40 episodes per 1000 patient-days in the heparin and rt-PA groups, respectively; P = 0.02). The risk of bacteremia from any cause was higher in the heparin group than in the rt-PA group by a factor of 3 (hazard ratio, 3.30; 95% CI, 1.18 to 9.22; P = 0.02). The risk of adverse events, including bleeding, was similar in the two groups. CONCLUSIONS: The use of rt-PA instead of heparin once weekly, as compared with the use of heparin three times a week, as a locking solution for central venous catheters significantly reduced the incidence of catheter malfunction and bacteremia. (Current Controlled Trials number, ISRCTN35253449.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Cited by
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Self-citationGuía Clínica Española del Acceso Vascular para Hemodiálisis
Ibeas, J., Roca-Tey, R., Vallespín, J., Moreno, T., Moñux, G., Martí-Monrós, A., del Pozo, J. L., Gruss, E., Ramírez de Arellano, M., Fontseré, N., et al. (2017) · Nefrología · doi:10.1016/j.nefro.2017.11.004 · Cited by 214
Renal replacement therapy in adult and pediatric intensive care
Vinsonneau, C., Allain-Launay, E., Blayau, C., Darmon, M., du Cheyron, D., Gaillot, T., Honore, P. M., Javouhey, E., Krummel, T., Lahoche, A., et al. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0093-5 · Cited by 151
UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis
Aitken, E., Anijeet, H., Ashby, D., Barrow, W., Calder, F., Dowds, B., Fielding, C., Gilbert, J., Jones, R., Karunanithy, N., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04374-y · Cited by 42
Metadata
- Authors
- Hemmelgarn, B. R., Moist, L. M., Lok, C. E., Tonelli, M., Manns, B. J., Holden, R. M., LeBlanc, M., Faris, P., Barre, P., Zhang, J., & Scott-Douglas, N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-01-27
- Volume
- 364
- Issue
- 4
- Pages
- 303-312
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124436945
- Cited by
- 206
- References
- 1
- FWCI
- 33.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator. https://app.cochat.ai/papers/10.1056/nejmoa1011376
- The paper
- Hemmelgarn, B. R., Moist, L. M., Lok, C. E., Tonelli, M., Manns, B. J., Holden, R. M., LeBlanc, M., Faris, P., Barre, P., Zhang, J., & Scott-Douglas, N. (2011). Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1011376
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.